Drug Type Recombinant protein |
Synonyms CDNF, CDNF-protein, Cerebral dopamine neurotrophic factor(Herantis Pharma) + [4] |
Target- |
Action modulators |
Mechanism Neurons modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Phase 2 | - | - | |
Parkinson Disease | Phase 2 | - | - | |
Alzheimer Disease | Preclinical | - | - | |
Alzheimer Disease | Preclinical | - | - | |
Alzheimer Disease | Preclinical | - | - | |
Amyotrophic Lateral Sclerosis | Preclinical | - | - | |
Amyotrophic Lateral Sclerosis | Preclinical | - | - | |
Amyotrophic Lateral Sclerosis | Preclinical | - | - |
Not Applicable | - | - | pyjrstqnth(zexfkdurai) = kprlbwjocu uegturufyz (nclotcxcys, 81.33) | - | 01 Jul 2018 | ||
PBS | pyjrstqnth(zexfkdurai) = cwzejxvqky uegturufyz (nclotcxcys, 40.89) |